Dr. Roman Groisberg explains the TRACK Study’s Virtual Molecular Tumor Board.

Dr. Roman Grosiberg on TRACK’s Virtual Molecular Tumor Board and its importance in interpreting genomic reports for patients anywhere in the US, recorded on Rare Cancer Day 2020.